Photo credit: Tumisu / pixabay.com
The Vaccines journal has published data on the effectiveness of the Russian vaccine Sputnik V against new strains of coronavirus infection. This was announced by the Russian Direct Investment Fund (RDIF), TASS reports.
The studies conducted by the Gamaleya Center indicate that Sputnik V vaccination contributes to the production of protective antibodies against strains identified in the UK, South Africa, Brazil, India, as well as other variants of the virus. It turned out that the decrease in the level of neutralizing activity in Sputnik V for a number of strains is much lower than that of other vaccines.
Currently, Sputnik V has passed registration in 67 states, which are populated by 3.5 billion people.
Russkiy Mir
reported earlier that an article on the Russian coronavirus vaccine Sputnik V was also published in the Nature scientific journal. The journal called the vaccine effective and safe. The article also notes that it has not yet been approved by the World Health Organization, although it is successfully used in dozens of countries.
Russkiy Mir
